Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Abramson: Systemic carboplatin for retinoblastoma: change in tumour size over time. (0.15 sec) 

Systemic carboplatin for retinoblastoma: change in tumour size over time

- nih.gov - Free from Publisher
DH Abramson, SD Lawrence, KL Beaverson, TC … - British Journal of Ophthalmology, 2005 - bjo.bmj.com
Results: 36 tumours were measured following one treatment: 34/36 (94.4%)
responded, with a 37.1% mean decrease in area (median = 37.0%; range
4.0%–76.7%). Mean reduction in basal diameter was 21.3% (med = 21.0%; ...
Cited by 5 - Related articles - BL Direct - All 10 versions

Targeting hypoxia, a novel treatment for advanced retinoblastoma

- iovs.org
H Boutrid, ME Jockovich, TG Murray, Y Pina, … - Investigative Ophthalmology & Visual Science, 2008 - ARVO
METHODS. Hypoxic and vascular areas in LH BETA T AG mouse retinal tumors were
measured using immunohistochemistry. The glycolytic inhibitor 2-deoxy-D-glucose
(2-DG) was used to test the efficacy of targeting hypoxic cells in ...
Cited by 3 - Related articles - All 4 versions

The Wnt signaling pathway has tumor suppressor properties in retinoblastoma


S Tell, H Yi, ME Jockovich, TG Murray, AS … - Biochemical and Biophysical Research …, 2006 - Elsevier
Retinoblastoma is a pediatric retinal tumor caused by mutational inactivation of
the tumor suppressor pRb. Additional genetic changes, as yet unidentified, are
believed to be required for tumor initiation. Mutations in the Wnt ...
Cited by 5 - Related articles - All 5 versions

Vessel Targeting Increases Hypoxia in a Murine Model of Retinoblastoma


H Boutrid, Y Pina, C Cebulla, WJ Feuer, TJ … - Investigative Ophthalmology & Visual Science, 2009 - ARVO
Hinda Boutrid, 1 Yolanda Piña, 1 Colleen M. Cebulla, 1 William J. Feuer, 1
Theodore J. Lampidis, 2 Maria- ... Elena Jockovich, 1 and Timothy G. Murray 1
... 1. Bascom Palmer Eye Institute, Department of Ophthalmology, ...
Related articles - All 2 versions

SRPK1: A cisplatin sensitive protein expressed in retinoblastoma


S Krishnakumar, A Mohan, M Kandalam, HL … - PEDIATRIC BLOOD AND CANCER, 2008 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Related articles - BL Direct - All 2 versions

Differential sensitivity to 2-deoxy-D-glucose between two pancreatic cell lines correlates …


JC Maher, N Savaraj, W Priebe, H Liu, TJ … - Pancreas, 2005 - journals.lww.com
Results: Under normal oxygen tension, we find that the pancreatic cell line MIA
PaCa2 (1420) is 7 times more sensitive to 2-DG and equally sensitive to oxamate,
as compared with Panc-1 (1469). Lactate levels in both cell types are ...
Cited by 9 - Related articles - All 4 versions

Immunotherapy of hepatoma with a monoclonal antibody against murine endoglin


GH Tan, FY Huang, H Wang, YH Huang, YY … - WORLD JOURNAL OF GASTROENTEROLOGY, 2007 - wjgnet.com
METHODS: A monoclonal antibody against murine endoglin was purified by affinity
chromatography and passively transfused through tail veins in two murine
hepatoma models. Tumor volume and survival time were observed at three-day ...
Cited by 2 - Related articles - Cached - BL Direct - All 5 versions

Conservative treatment of tumors of the retina at the Curie Institute. 5-year ophthalmologic …


C Haye, P Schlienger, R Calle, JR Vilcoq, B … - Bulletin du cancer, 1986 - ncbi.nlm.nih.gov
The authors report a retrospective study of 129 children with retino-blastoma
treated from 1963 to 1977 at the Institute Curie by enucleation of the worst eye
and conservative irradiation of the other eye; this irradiation was ...
Cited by 2 - Related articles

[CITATION] Ocular Oncology


DH Abramson, AC Schefler, 2003 - Marcel Dekker New York
Cited by 2 - Related articles

Hypoxia-inducible factor-1 confers resistance to the glycolytic inhibitor 2-deoxy-D-glucose

- aacrjournals.org
JC Maher, M Wangpaichitr, N Savaraj, M … - Molecular cancer therapeutics, 2007 - AACR
Solid tumors contain regions of poor and/or aberrant vasculature, which results
in reduced blood flow and, consequently, oxygen delivery to cells growing in
those areas (1). The hypoxic environment, in turn, leads to slowed growth, ...
Cited by 11 - Related articles - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google